Meerut Reporter

Angioedema Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharma

 Breaking News
  • No posts were found

Angioedema Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharma

February 28
05:38 2023
Angioedema Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies - Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharma
The Angioedema market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Angioedema pipeline products will significantly revolutionize the Angioedema market dynamics.

DelveInsight’s “Angioedema Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Angioedema, historical and forecasted epidemiology as well as the Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Angioedema market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Angioedema market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Angioedema Market Insights

 

Angioedema Overview

Angioedema is a condition when a body component becomes unexpectedly enlarged. If an allergic reaction is what caused the swelling, you will typically experience a raised, itchy rash (hives). The face, especially the lips, mouth, and eyelids, is one of the parts of the body that frequently affects the feet or hands.

 

Some of the key facts of the Angioedema Market Report: 

  • The Angioedema market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • Hereditary angioedema affects 1 in every 50,000 people globally, with reported prevalence ranges from 1:10,000 to 1:150,000
  • Angioedema is a common condition, affecting about 10-20% of people during their life, although some types are more common than others
  • Key Angioedema Companies: Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, Takeda, Shire, Pharming Group, and others
  • Key Angioedema Therapies: Lanadelumab, DX-2930, Icatibant, Donidalorsen, BCX7353, IONIS-PKK-LRx, KVD900, CSL312, and others

 

Get a Free sample for the Angioedema Market Report –

https://www.delveinsight.com/sample-request/angioedema-market

 

Key benefits of the Angioedema Market report:

  1. Angioedema market report covers a descriptive overview and comprehensive insight of the Angioedema Epidemiology and Angioedema market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Angioedema market report provides insights on the current and emerging therapies.
  3. Angioedema market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Angioedema market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Angioedema market.

 

Download the report to understand which factors are driving Angioedema epidemiology trends @ Angioedema Epidemiological Insights 

 

Angioedema Market  

The dynamics of the Angioedema market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

 

Angioedema Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Angioedema Epidemiology Segmentation:

The Angioedema market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Angioedema
  • Prevalent Cases of Angioedema by severity
  • Gender-specific Prevalence of Angioedema
  • Diagnosed Cases of Episodic and Chronic Angioedema

 

Angioedema Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Angioedema market or expected to get launched during the study period. The analysis covers Angioedema market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Angioedema Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Angioedema market share @ Angioedema market forecast 

 

Angioedema Therapies and Key Companies

  • Lanadelumab: Takeda Development Center Americas, Inc.
  • DX-2930: Dyax Corp.
  • Icatibant: Takeda
  • Donidalorsen: Ionis Pharmaceuticals, Inc.

 

Angioedema Market Strengths

  • Increasing identification of a novel genetic mutation in various regions warranting further focus on the types and associated pathophysiology, including recognition of hormonal changes

 

Scope of the Angioedema Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Angioedema Companies: Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, Takeda, Shire, Pharming Group, and others
  • Key Angioedema Therapies: Lanadelumab, DX-2930, Icatibant, Donidalorsen, BCX7353, IONIS-PKK-LRx, KVD900, CSL312, and others
  • Angioedema Therapeutic Assessment: Angioedema current marketed and Angioedema emerging therapies
  • Angioedema Market Dynamics: Angioedema market drivers and Angioedema market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Angioedema Unmet Needs, KOL’s views, Analyst’s views, Angioedema Market Access and Reimbursement 

 

Angioedema Market Opportunities

  • Proliferating demand for therapies with improved patient compliance, fewer side effects, improved resistance profile, and long-acting therapies

 

Table of Contents 

1. Angioedema Market Report Introduction

2. Executive Summary for Angioedema

3. SWOT analysis of Angioedema

4. Angioedema Patient Share (%) Overview at a Glance

5. Angioedema Market Overview at a Glance

6. Angioedema Disease Background and Overview

7. Angioedema Epidemiology and Patient Population

8. Country-Specific Patient Population of Angioedema 

9. Angioedema Current Treatment and Medical Practices

10. Angioedema Unmet Needs

11. Angioedema Emerging Therapies

12. Angioedema Market Outlook

13. Country-Wise Angioedema Market Analysis (2019–2032)

14. Angioedema Market Access and Reimbursement of Therapies

15. Angioedema Market Drivers

16. Angioedema Market Barriers

17.  Angioedema Appendix

18. Angioedema Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Angioedema treatment, visit @ Angioedema Medications 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services